Guicciardi M Eugenia, Bronk Steven F, Werneburg Nathan W, Yin Xiao-Ming, Gores Gregory J
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.
Gastroenterology. 2005 Jul;129(1):269-84. doi: 10.1053/j.gastro.2005.05.022.
BACKGROUND & AIMS: During tumor necrosis factor alpha-mediated hepatocyte cytotoxicity, cathepsin B is released from lysosomes and contributes to apoptosis by indirectly promoting mitochondrial dysfunction. How this lysosomal pathway mediates mitochondrial dysfunction is unclear. Because Bcl-2 family proteins and caspase 2 have been implicated in proximal apoptosis-signaling pathways, we examined the role of these proteins in tumor necrosis factor alpha-induced lysosomal permeabilization and cathepsin B-mediated mitochondrial dysfunction.
Studies were performed in primary hepatocytes from wild-type cathepsin B knockout, Bid knockout, and caspase 2 knockout mice and in the rat hepatoma cell line McArdle7777 by using tumor necrosis factor alpha/actinomycin D.
Studies in wild-type and Bid knockout hepatocytes showed that tumor necrosis factor alpha-mediated lysosomal permeabilization is Bid dependent. After tumor necrosis factor alpha/actinomycin D treatment, caspase 2 activity increased severalfold in wild-type hepatocytes, whereas minimal activity was observed in hepatocytes from cathepsin B knockout mice or in hepatoma cells treated with a cathepsin B inhibitor. In contrast, Bax was activated independently of cathepsin B. Pharmacological, genetic, or small interfering RNA-mediated inhibition of caspase 2 attenuated tumor necrosis factor alpha-mediated mitochondrial dysfunction, downstream caspase activation, and hepatocyte apoptosis.
These data suggest that tumor necrosis factor alpha triggers Bid-dependent lysosomal permeabilization, followed by release of cathepsin B into the cytosol and activation of caspase 2. Caspase 2 then facilitates efficient mitochondrial cytochrome c release and apoptosis.
在肿瘤坏死因子α介导的肝细胞细胞毒性过程中,组织蛋白酶B从溶酶体中释放出来,并通过间接促进线粒体功能障碍而导致细胞凋亡。这种溶酶体途径如何介导线粒体功能障碍尚不清楚。由于Bcl-2家族蛋白和半胱天冬酶2与近端凋亡信号通路有关,我们研究了这些蛋白在肿瘤坏死因子α诱导的溶酶体通透性增加和组织蛋白酶B介导的线粒体功能障碍中的作用。
通过使用肿瘤坏死因子α/放线菌素D,对野生型、组织蛋白酶B基因敲除、Bid基因敲除和半胱天冬酶2基因敲除小鼠的原代肝细胞以及大鼠肝癌细胞系McArdle7777进行研究。
对野生型和Bid基因敲除肝细胞的研究表明,肿瘤坏死因子α介导的溶酶体通透性增加依赖于Bid。在肿瘤坏死因子α/放线菌素D处理后,野生型肝细胞中的半胱天冬酶2活性增加了几倍,而在组织蛋白酶B基因敲除小鼠的肝细胞或用组织蛋白酶B抑制剂处理的肝癌细胞中观察到的活性极小。相比之下,Bax的激活独立于组织蛋白酶B。药理学、遗传学或小干扰RNA介导的对半胱天冬酶2的抑制减弱了肿瘤坏死因子α介导的线粒体功能障碍、下游半胱天冬酶激活和肝细胞凋亡。
这些数据表明,肿瘤坏死因子α触发Bid依赖的溶酶体通透性增加,随后组织蛋白酶B释放到细胞质中并激活半胱天冬酶2。半胱天冬酶2随后促进线粒体细胞色素c的有效释放和细胞凋亡。